NCT04926298View on ClinicalTrials.gov

Glycemic Control Before, During and After the 2016 Paris Marathon

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

August 15, 2020

Primary Completion Date

September 15, 2020

Study Completion Date

December 6, 2020

Conditions
MarathonPhysical ActivityType 1 Diabetes MellitusEducationHypoglycemia
Trial Locations (1)

29200

University Hospital of Brest, Brest

All Listed Sponsors
lead

University Hospital, Brest

OTHER

NCT04926298 - Glycemic Control Before, During and After the 2016 Paris Marathon | Biotech Hunter | Biotech Hunter